Rise in prevalence of diabetes, lymphatic
diseases, increase in older age population, and rise in number of orthopedic
procedures due to increase in number of sports injuries & accidents are the
factors that are expected to drive the growth of the U.S.
compression therapy market during the forecast period. In addition, rise in
number of cases of deep vein thrombosis, leg ulcers, and varicose veins are
expected to drive the market growth in the coming years. Moreover,
technological advancements in the healthcare sector, rise in awareness
regarding the compression therapy, and advancements in the bandages &
compression stockings manufacturing industry are expected to boost the growth
of the U.S. compression therapy market during the forecast period. However,
rise in threats of complications, insufficient reimbursement policies for
compression therapies, low patient compliance, and adoption of substitute
therapies for certain indications are the major restraints that may hamper the
growth of the U.S. compression therapy market in the coming years.
Compression therapy is a simple & effective
process of applying external pressure to the lower limbs. It is used to treat
different chronic diseases. It involves wearing specially designed hosiery,
bandages, and tapes for evaluating blood circulation in legs. Compression
therapy is an effective technique used for conditions such as Venous
Thromboembolism (VTE), Deep Vein Thrombosis (DVT), chronic & diabetic
ulcers, post-thrombotic syndrome, and lymphedema. It reduces pathologically
increased venous pressure. In addition, it improves moment of joints and
tendons, and reduces inflammation. This treatment is prescribed to treat phlebitis,
post vein surgery, thrombosis, varicose veins, venous leg ulcers, and vein
thrombosis. Moreover, it is prescribed to prevent venous trouble during long
distance travel and pregnancy. During the therapy, vibration of muscles is
reduced and delayed soreness of muscle is prevented. Available products for
compression therapy include carolon stockings, farrow wraps, jobst ulcercare
compression stockings, and circaid juxta-lite.
Download PDF Report
Sample with statistical info @ https://www.alliedmarketresearch.com/request-toc-and-sample/4858
The U.S. compression therapy market is
segmented on the basis of technique, product, and application. Based on
technique, the market is bifurcated into dynamic compression therapy and static
compression therapy. On the basis of product, it is divided into compression
stockings, compression pumps, compression bandages, compression tapes, and
others. By application, it is segmented into deep vein thrombosis treatment,
varicose vein treatment, leg ulcer treatment, lymphedema treatment, and others.
Some of the major players operating in the
U.S. compression therapy market include Medtronic PLC, 3M Company, BSN Medical,
Bio Compression Systems, Inc., Paul Hartmann AG, Medi GmbH & Co. Kg,
Cardinal Health, Inc., Smith & Nephew PLC., Sanyleg S.R.L., Sigvaris,
Tactile Medical, Convatec Inc., Julius Zorn GmbH, Arjohuntleigh (Subsidiary of
Getinge Group), and DJO Global Inc.
KEY BENEFITS FOR
STAKEHOLDERS
- This report provides a detailed
quantitative analysis of the current market trends and market forecast
estimations from 2019 to 2026, which assists to identify the prevailing
U.S. compression therapy market opportunities.
- An in-depth market analysis includes study
of various regions and is anticipated to provide a detailed understanding
of the current trends to enable stakeholders to formulate region-specific
plans.
- A comprehensive analysis of the factors
that drive and restrain the growth of the market is provided.
- The projections in this report are made by
analyzing the current market trends and future market potential from 2019
to 2026, in terms of value.
- An extensive analysis of various regions
provides insights that is expected to allow companies to strategically
plan their business moves.
- Key market players within the market are
profiled in this report and their strategies are analyzed thoroughly,
which helps understand competitive outlook of the U.S. compression therapy
market.
No comments:
Post a Comment